The pharmaceutical industry has always been a high-stakes arena, where years of research, billions of dollars, and countless clinical trials culminate in a single therapy reaching patients. Despite tremendous advancements, the traditional drug discovery process remains time-consuming, costly, and fraught with uncertainty. Enter Artificial Intelligence (AI), a technological force poised to reshape every stage of drug development. From target identification to clinical trials and pharmacovigilance, AI is accelerating timelines, optimizing resources, and enabling smarter decision-making.
The AI in the drug discovery market reflects this transformative potential. Estim...
